Zyprexa
Steven M. Goldberg participated in $700 Million Settlement of Zyprexa Claims:
On June 7, 2005, Eli Lilly announced a $700 million settlement of approximately 8,000 cases that were filed against them for allegations that the atypical anti-psychotic drug Zyprexa caused them to develop diabetes and diabetes-related injuries. Steven M. Goldberg Co., LPA participated in this suit on behalf of hundreds of injured Ohio consumers and worked on behalf of their clients to reach this settlement.
Diabetes is a very serious condition with several serious complications. The lawsuits alleged that Eli Lilly, the manufacturer of the drug, failed to adequately warn patients and their doctors about the drug's known association with diabetes and other injuries.
Steven M. Goldberg Co. LPA and its affiliated counsel have also filed and/or actively participated in Vioxx, Heparin, Bextra, Celebrex, Yaz, Topamax, and Gadolinium lawsuits.
